ConductScience.org, home

Paper4449482

A membrane receptor protein for asialoglycoproteins.

Pricer WE and 4 others. Methods Enzymol, 1974. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. A membrane receptor protein for asialoglycoproteins. Papers, record 4449482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4449482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A membrane receptor protein for asialoglycoproteins.
PubMed
Journal
Methods Enzymol
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2019-07-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pricer WE JrW E
2Hudgin RLR L
3Ashwell GG
4Stockert RJR J
5Morell AGA G

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell MembraneMajor topic
GlycoproteinsMajor topic
Sialic AcidsMajor topic
Animals
Chromatography, Affinity
Chromatography, Gel
Ligands
Liver
Orosomucoid
Polyethylene Glycols
Protein Binding
Rabbits
Sepharose

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
41068471RNA-based therapeutic opportunities for the treatment of kidney diseases.Nat Rev Nephrol2026https://conductscience.org/library/papers/41068471PubMed
39262805Recent progress in gene therapy for familial hypercholesterolemia treatment.iScience2024https://conductscience.org/library/papers/39262805PubMed
33861634Impact of Serum Proteins on the Uptake and RNAi Activity of GalNAc-Conjugated siRNAs.Nucleic Acid Ther2021https://conductscience.org/library/papers/33861634PubMed
31792921Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran.Mol Diagn Ther2020https://conductscience.org/library/papers/31792921PubMed
29456020Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.Mol Ther2018https://conductscience.org/library/papers/29456020PubMed
28988716Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.Mol Ther2018https://conductscience.org/library/papers/28988716PubMed
27941121A Novel Copolymer-Based Functional SPECT/MR Imaging Agent for Asialoglycoprotein Receptor Targeting.Mol Imaging2016https://conductscience.org/library/papers/27941121PubMed
27877525Cell membrane-inspired phospholipid polymers for developing medical devices with excellent biointerfaces.Sci Technol Adv Mater2012https://conductscience.org/library/papers/27877525PubMed
27680668Sialidase Unmasks Mucin Domain Epitopes of Lubricin.J Histochem Cytochem2016https://conductscience.org/library/papers/27680668PubMed
26000135Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity.Auto Immun Highlights2012https://conductscience.org/library/papers/26000135PubMed
25621663Protein glycosylation in cancer.Annu Rev Pathol2015https://conductscience.org/library/papers/25621663PubMed
24914343Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry.World J Gastroenterol2014https://conductscience.org/library/papers/24914343PubMed
22563238Imiglucerase in the treatment of Gaucher disease: a history and perspective.Drug Des Devel Ther2012https://conductscience.org/library/papers/22563238PubMed
22545002In vivo clearance of alpha-1 acid glycoprotein is influenced by the extent of its N-linked glycosylation and by its interaction with the vessel wall.J Biomed Biotechnol2012https://conductscience.org/library/papers/22545002PubMed
21781240The role of lectins and glycans in platelet clearance.J Thromb Haemost2011https://conductscience.org/library/papers/21781240PubMed
20461061Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.Mol Ther2010https://conductscience.org/library/papers/20461061PubMed
20144401Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.J Diabetes Sci Technol2009https://conductscience.org/library/papers/20144401PubMed
20055529Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.BioDrugs2010https://conductscience.org/library/papers/20055529PubMed
17512493New liver cell mutants defective in the endocytic pathway.Biochim Biophys Acta2007https://conductscience.org/library/papers/17512493PubMed
15972524Bovine intestinal alkaline phosphatase attenuates the inflammatory response in secondary peritonitis in mice.Infect Immun2005https://conductscience.org/library/papers/15972524PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4449482

GET https://conductscience.org/api/papers/v1/4449482/cited_by?page=2